A similar expression pattern was detected for Inha, which encodes Inhibin A, a protein implicated in 5-FU resistance in colon cancer cells (Zhang et al., 2024), and, to a lesser extent, the Gpc1, a gene associated with EMT activation, increased invasion and migration in CRC cells, and proposed as a biomarker for stage III CRC relapse (Li et al., 2017). The gene discussed is INHA; the disease is malignant colon neoplasm.